Related Experiment Video
Updated: Nov 21, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
Delivery and adherence with inhaled therapy in asthma
Martyn F Biddiscombe1, Omar S Usmani2
1National Heart and Lung Institute, Royal Brompton Hospital, Imperial College London, London, UK - m.biddiscombe@imperial.ac.uk.
Patients struggle with inhaler use for asthma, impacting treatment adherence and disease control. Innovations in inhaler design are crucial for improving patient technique and achieving better asthma management outcomes.
Area of Science:
- Respiratory Medicine
- Pharmacology
- Medical Device Engineering
Background:
- Inhaled medications are vital for managing respiratory diseases like asthma, with numerous device-drug combinations available.
- Despite advancements, correct and consistent inhaler use remains a significant challenge for patients, hindering effective asthma control.
- Uncontrolled asthma, even with potent treatments, leads to considerable morbidity and mortality.
Purpose of the Study:
- To review the challenges patients face with inhaler usage and treatment adherence in asthma management.
- To explore how innovations in inhaler design can potentially improve patient technique and adherence.
Main Methods:
- Literature review of studies examining patient inhaler technique and adherence.
- Analysis of current challenges in asthma treatment adherence.
- Exploration of potential solutions through novel inhaler designs.
Main Results:
- A significant gap exists between the intended simplicity of inhalers and actual patient usability.
- Poor adherence to inhaled therapies is a major barrier to achieving optimal asthma control.
- Patient-related factors significantly contribute to difficulties in correct inhaler operation.
Conclusions:
- Improving inhaler usability and patient adherence is critical for enhancing asthma management.
- Innovative inhaler designs hold promise for addressing current limitations and improving therapeutic outcomes.
- Further research into user-centered design is needed to optimize inhaled therapy delivery.
Related Concept Videos
Inhaled Medications
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Asthma-IV: Nursing Management
First, in...
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Additional Routes of Drug Administration
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...

